Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis
Open Access
- 1 October 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (42), 28845-28855
- https://doi.org/10.1074/jbc.m109.042150
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Dicer, Drosha, and Outcomes in Patients with Ovarian CancerThe New England Journal of Medicine, 2008
- Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNACancer Research, 2008
- Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivoThe Journal of Experimental Medicine, 2008
- Cancer-related inflammationNature, 2008
- Inhibition of Photocarcinogenesis by Platelet-Activating Factor or Serotonin Receptor AntagonistsCancer Research, 2008
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4Cell, 2008
- Immune cells as mediators of solid tumor metastasisCancer and Metastasis Reviews, 2007
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences of the United States of America, 1968
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959